The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes

This review describes a key role for mononuclear phagocytes in the pathogenesis of major psychiatric disorders. There is accumulating evidence for activation of microglia (histopathology and PET scans) and circulating monocytes (enhanced gene expression of immune genes, an overproduction of monocyte/macrophage‐related cytokines) in patients with bipolar disorder, major depressive disorder, and schizophrenia. These data are strengthened by observations in animal models, such as the MIA models, the chronic stress models, and the NOD mouse model. In these animal models of depressive‐, anxiety‐, and schizophrenia‐like behavior, similar activations of microglia and circulating monocytes can be found. These animal models also make in‐depth pathogenic studies possible and show that microglia activation impacts neuronal development and function in brain areas congruent with the altered depressive and schizophrenia‐like behaviors.

[1]  J. Sidney,et al.  Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis , 2013, Journal of Neuroinflammation.

[2]  D. Cohen,et al.  Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome , 2012, Psychoneuroendocrinology.

[3]  B. Bogerts,et al.  Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[4]  J. Sheridan,et al.  Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice , 2012, Psychoneuroendocrinology.

[5]  F. Walker,et al.  Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. , 2012, Cerebral cortex.

[6]  A. Myint Kynurenines: from the perspective of major psychiatric disorders , 2012, The FEBS journal.

[7]  D. Brooks,et al.  Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation , 2012, Journal of viral hepatitis.

[8]  J. Campisi,et al.  Stress-induced facilitation of host response to bacterial challenge in F344 rats is dependent on extracellular heat shock protein 72 and independent of alpha beta T cells , 2012, Stress.

[9]  O. Pascual,et al.  Physiological roles of microglia during development , 2011, Journal of neurochemistry.

[10]  P. Bickford,et al.  CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity , 2011, The Journal of Neuroscience.

[11]  A. Nimmerjahn,et al.  The Role of Microglia in the Healthy Brain , 2011, The Journal of Neuroscience.

[12]  J. Leza,et al.  Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression , 2011, Journal of Neuroinflammation.

[13]  C. Glass,et al.  Microglial cell origin and phenotypes in health and disease , 2011, Nature Reviews Immunology.

[14]  D. Beversdorf,et al.  Poorer self-rated health is associated with elevated inflammatory markers among older adults , 2011, Psychoneuroendocrinology.

[15]  Michael J. Cole,et al.  Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats , 2011, Neurobiology of Aging.

[16]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  C. Limatola,et al.  CX3CR1 Deficiency Alters Hippocampal-Dependent Plasticity Phenomena Blunting the Effects of Enriched Environment , 2011, Front. Cell. Neurosci..

[18]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[19]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[20]  G. Juckel,et al.  Microglial activation in a neuroinflammational animal model of schizophrenia — a pilot study , 2011, Schizophrenia Research.

[21]  B. Bogerts,et al.  Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? , 2011, Journal of Neuroinflammation.

[22]  H. Anisman,et al.  Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges , 2011, Brain, Behavior, and Immunity.

[23]  G. Onambélé-Pearson,et al.  Is there a morning-to-evening difference in the acute IL-6 and cortisol responses to resistance exercise? , 2011, Cytokine.

[24]  W. Nolen,et al.  The activation of monocyte and T cell networks in patients with bipolar disorder , 2011, Brain, Behavior, and Immunity.

[25]  K. Weigelt,et al.  TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors , 2011, Brain, Behavior, and Immunity.

[26]  W. Nolen,et al.  An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. , 2011, The international journal of neuropsychopharmacology.

[27]  H. Onoe,et al.  In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl Ester , 2011, The Journal of Nuclear Medicine.

[28]  K. Kristensson Microbes' roadmap to neurons , 2011, Nature Reviews Neuroscience.

[29]  P. Terpstra,et al.  Poor replication of candidate genes for major depressive disorder using genome-wide association data , 2011, Molecular Psychiatry.

[30]  B. Leonard,et al.  The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  Lisa Goehler,et al.  In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  R. Nelson,et al.  β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat , 2011, The Journal of Neuroscience.

[33]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[34]  P. Legendre,et al.  Pattern of invasion of the embryonic mouse spinal cord by microglial cells at the time of the onset of functional neuronal networks , 2011, Glia.

[35]  R. Butterworth Hepatic encephalopathy: A central neuroinflammatory disorder? , 2011, Hepatology.

[36]  A. Majewska,et al.  A role for microglia in synaptic plasticity? , 2011, Communicative & integrative biology.

[37]  S. Nutt,et al.  Endogenous microglia regulate development of embryonic cortical precursor cells , 2011, Journal of neuroscience research.

[38]  William C Clegern,et al.  Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss. , 2011, Sleep.

[39]  F. Peri,et al.  Microglia in the developing brain: from immunity to behaviour , 2011, Current Opinion in Neurobiology.

[40]  Robert B. Innis,et al.  Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.

[41]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[42]  Ania K. Majewska,et al.  Microglial Interactions with Synapses Are Modulated by Visual Experience , 2010, PLoS biology.

[43]  Dan Cohen,et al.  Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. , 2010, The international journal of neuropsychopharmacology.

[44]  O. Pascual,et al.  Glia: The many ways to modulate synaptic plasticity , 2010, Neurochemistry International.

[45]  G. Enikolopov,et al.  Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. , 2010, Cell stem cell.

[46]  D. Pow,et al.  Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions , 2010, Brain, Behavior, and Immunity.

[47]  P. Mortensen,et al.  Autoimmune diseases, bipolar disorder, and non-affective psychosis. , 2010, Bipolar disorders.

[48]  Peilin Jia,et al.  Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data , 2010, Schizophrenia Research.

[49]  R. Dantzer,et al.  Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures , 2010, Journal of Neuroinflammation.

[50]  P. Boksa Effects of prenatal infection on brain development and behavior: A review of findings from animal models , 2010, Brain, Behavior, and Immunity.

[51]  B. Leonard The concept of depression as a dysfunction of the immune system. , 2010, Current immunology reviews.

[52]  R. Kahn,et al.  Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. , 2010, The Journal of clinical psychiatry.

[53]  S. Poole,et al.  Leptin regulates leukocyte recruitment into the brain following systemic LPS-induced inflammation , 2010, Molecular Psychiatry.

[54]  B. Castellano,et al.  Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia , 2010, Molecular Psychiatry.

[55]  Huiguang He,et al.  Glutamatergic and Resting-State Functional Connectivity Correlates of Severity in Major Depression – The Role of Pregenual Anterior Cingulate Cortex and Anterior Insula , 2010, Front. Syst. Neurosci..

[56]  G. Luheshi,et al.  Leptin modulates cell morphology and cytokine release in microglia , 2010, Brain, Behavior, and Immunity.

[57]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[58]  Abraham Z. Snyder,et al.  Maturing Thalamocortical Functional Connectivity Across Development , 2010, Front. Syst. Neurosci..

[59]  W. Banks,et al.  The blood–brain barrier and immune function and dysfunction , 2010, Neurobiology of Disease.

[60]  R. Drexhage,et al.  The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder , 2010, Expert review of neurotherapeutics.

[61]  P. Patterson Immune involvement in schizophrenia and autism: Etiology, pathology and animal models , 2009, Behavioural Brain Research.

[62]  J. Feldon,et al.  Neural basis of psychosis-related behaviour in the infection model of schizophrenia , 2009, Behavioural Brain Research.

[63]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[64]  Tony Wyss-Coray,et al.  Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little? , 2009, Neuron.

[65]  Benjamin S. Lankow,et al.  Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress , 2009, Brain, Behavior, and Immunity.

[66]  Jennifer L Martin,et al.  To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers , 2009, Brain, Behavior, and Immunity.

[67]  R. Kahn,et al.  Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. , 2009, Archives of general psychiatry.

[68]  J. Calderó,et al.  Development of microglia in the chick embryo spinal cord: Implications in the regulation of motoneuronal survival and death , 2009, Journal of neuroscience research.

[69]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[70]  E. Brietzke,et al.  Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. , 2009, Journal of affective disorders.

[71]  Sunhee C. Lee,et al.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain , 2009, Neuropathology and applied neurobiology.

[72]  B. Kirkpatrick,et al.  Metabolic profile of antipsychotic-naive individuals with non-affective psychosis , 2009, British Journal of Psychiatry.

[73]  R. Lam,et al.  Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. , 2009, The international journal of neuropsychopharmacology.

[74]  Peter Boesiger,et al.  The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. , 2009, Archives of general psychiatry.

[75]  R. Dantzer,et al.  Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice , 2009, Molecular Psychiatry.

[76]  H. Steinbusch,et al.  Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients , 2009, Neuropsychobiology.

[77]  M. James,et al.  [11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis , 2009, Molecular Imaging and Biology.

[78]  Jing-ping Zhao,et al.  The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia , 2009, Biological Psychiatry.

[79]  O. Lindvall,et al.  Brain inflammation and adult neurogenesis: The dual role of microglia , 2009, Neuroscience.

[80]  P. Scully,et al.  Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.

[81]  S. Bustin,et al.  Altered monocyte cyclo‐oxygenase response in non‐obese diabetic mice , 2009, Clinical and experimental immunology.

[82]  D. Janigro,et al.  Do Systemic Inflammation and Blood-Brain Barrier Failure Play a Role in Pediatric Psychosis? , 2009 .

[83]  P. Sarret,et al.  Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: A novel animal model for cerebral palsy in very premature infants , 2009, Neuroscience.

[84]  S. Poole,et al.  Selective contribution of interleukin‐6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice , 2008, The Journal of comparative neurology.

[85]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[86]  R. Dierckx,et al.  PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. , 2008, Current pharmaceutical design.

[87]  R. Dantzer,et al.  Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior , 2008, Brain, Behavior, and Immunity.

[88]  P. Scully,et al.  Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia , 2008, Psychiatry Research.

[89]  A. Triller,et al.  Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor , 2008, The Journal of Neuroscience.

[90]  M. Teixeira,et al.  Increased Serum Levels of Inflammatory Markers in Chronic Institutionalized Patients with Schizophrenia , 2008, Neuroimmunomodulation.

[91]  E. Réal,et al.  Prenatal Activation of Microglia Induces Delayed Impairment of Glutamatergic Synaptic Function , 2008, PloS one.

[92]  I. Goshen,et al.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.

[93]  D. Cohen,et al.  Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: Association with the metabolic syndrome in patients? , 2008, Schizophrenia Research.

[94]  J. Borrell NEUROBEHAVIORAL AND IMMUNOLOGICAL CONSEQUENCES OF PRENATAL IMMUNE ACTIVATION IN RATS , 2008, Schizophrenia Research.

[95]  C. Nüsslein-Volhard,et al.  Live Imaging of Neuronal Degradation by Microglia Reveals a Role for v0-ATPase a1 in Phagosomal Fusion In Vivo , 2008, Cell.

[96]  H. Drexhage,et al.  Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse , 2008, Journal of leukocyte biology.

[97]  Emmanuel Stip,et al.  Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.

[98]  W. Nolen,et al.  A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.

[99]  L. Hranov,et al.  Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial , 2008, The Lancet.

[100]  J. Koo,et al.  IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.

[101]  N. Ozaki,et al.  A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression , 2008, Stress.

[102]  John D. Lambris,et al.  The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.

[103]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[104]  M. E. Hernández,et al.  Immune variations in bipolar disorder: phasic differences. , 2007, Bipolar disorders.

[105]  B. Leonard Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.

[106]  B. Castellano,et al.  Neurobehavioral and Immunological Consequences of Prenatal Immune Activation in Rats. Influence of Antipsychotics , 2007, Neuropsychopharmacology.

[107]  W. Banks,et al.  Brain-immune communication pathways , 2007, Brain, Behavior, and Immunity.

[108]  R. Kahn,et al.  Is Autoimmune Thyroiditis Part of the Genetic Vulnerability (or an Endophenotype) for Bipolar Disorder? , 2007, Biological Psychiatry.

[109]  B. Keefe Interferon-induced depression in hepatitis C: An update , 2007, Current psychiatry reports.

[110]  O. Muzik,et al.  Microglial Activation in Perinatal Rabbit Brain Induced by Intrauterine Inflammation: Detection with 11C-(R)-PK11195 and Small-Animal PET , 2007, Journal of Nuclear Medicine.

[111]  R. Dantzer,et al.  Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior , 2007, Psychoneuroendocrinology.

[112]  H. Anisman,et al.  Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: Moderation by social stressors , 2007, Brain, Behavior, and Immunity.

[113]  A. Bessis,et al.  Microglial control of neuronal death and synaptic properties , 2007, Glia.

[114]  R. Yoshimura,et al.  Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients , 2007, International clinical psychopharmacology.

[115]  D. Steindler,et al.  Microglia instruct subventricular zone neurogenesis , 2006, Glia.

[116]  H. Hagberg,et al.  Lipopolysaccharide-induced inflammation and perinatal brain injury. , 2006, Seminars in fetal & neonatal medicine.

[117]  H. Nawa,et al.  Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines , 2006, Neuroscience Research.

[118]  R. Dierckx,et al.  Nuclear imaging of inflammation in neurologic and psychiatric disorders. , 2006, Current clinical pharmacology.

[119]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[120]  B. Bogerts,et al.  Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.

[121]  G. Parker,et al.  Omega-3 fatty acids and mood disorders. , 2006, The American journal of psychiatry.

[122]  N. Berman,et al.  Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection , 2006, Neuroscience Letters.

[123]  Wei Wei,et al.  Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. , 2006, Toxicology letters.

[124]  H. Hansson,et al.  Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[125]  D. Cohen,et al.  Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment , 2006, European Neuropsychopharmacology.

[126]  D. Cohen,et al.  Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. , 2006, Diabetes care.

[127]  T. Möller,et al.  Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.

[128]  P. Scully,et al.  Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. , 2006, Journal of affective disorders.

[129]  T. Kondo,et al.  Enhanced expression of brain interferon‐α and serotonin transporter in immunologically induced fatigue in rats , 2005, The European journal of neuroscience.

[130]  I. Janszky,et al.  Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease , 2005, Brain, Behavior, and Immunity.

[131]  S. Tzeng,et al.  Tumor necrosis factor-α and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture , 2005, Brain Research.

[132]  T. Guilarte,et al.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS , 2005, Journal of NeuroVirology.

[133]  V. Bolivar,et al.  Behavioral differences among fourteen inbred mouse strains commonly used as disease models. , 2005, Comparative medicine.

[134]  H. Drexhage,et al.  Diabetes‐prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage‐like cells in vitro , 2005, Journal of leukocyte biology.

[135]  Y. Pang,et al.  Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. , 2005, Brain research. Developmental brain research.

[136]  E. Lewandowska,et al.  Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. , 2005, Folia neuropathologica.

[137]  L. Moldawer,et al.  Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages. , 2005, Journal of autoimmunity.

[138]  Y. Sorokin,et al.  Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy , 2005, Neuropharmacology.

[139]  L. Smith,et al.  Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. , 2005, Current opinion in pharmacology.

[140]  J. Hell,et al.  Thrombospondins Are Astrocyte-Secreted Proteins that Promote CNS Synaptogenesis , 2005, Cell.

[141]  M. Mallat,et al.  Phagocytosis in the developing CNS: more than clearing the corpses , 2005, Current Opinion in Neurobiology.

[142]  J. Lauriello,et al.  Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. , 2005, The American journal of psychiatry.

[143]  E. Gundelfinger,et al.  Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse , 2004, The Journal of Neuroscience.

[144]  D. Diamond,et al.  Cat exposure induces both intra- and extracellular Hsp72: the role of adrenal hormones , 2004, Psychoneuroendocrinology.

[145]  Å. Lernmark,et al.  A high prevalence of organ-specific autoimmunity in patients with bipolar disorder , 2004, Biological Psychiatry.

[146]  X. Zhang,et al.  Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. , 2004, The Journal of clinical psychiatry.

[147]  Deanna L. Taylor,et al.  Microglia release activators of neuronal proliferation mediated by activation of mitogen‐activated protein kinase, phosphatidylinositol‐3‐kinase/Akt and delta–Notch signalling cascades , 2004, Journal of neurochemistry.

[148]  D. Jezova,et al.  Prenatal Immune Challenge Affects Growth, Behavior, and Brain Dopamine in Offspring , 2004, Annals of the New York Academy of Sciences.

[149]  F. Sedel,et al.  Macrophage-Derived Tumor Necrosis Factor α, an Early Developmental Signal for Motoneuron Death , 2004, The Journal of Neuroscience.

[150]  N. Rooijen,et al.  Microglia Promote the Death of Developing Purkinje Cells , 2004, Neuron.

[151]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[152]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[153]  S. Haeberlein,et al.  Migration and differentiation of neural precursor cells can be directed by microglia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[154]  T. Kondo,et al.  Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue , 2003, Neuroscience.

[155]  H. Takase,et al.  Postoperative confusion in schizophrenic patients is affected by interleukin-6. , 2003, Journal of clinical anesthesia.

[156]  U. Grohmann,et al.  A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice , 2003, The Journal of experimental medicine.

[157]  Rebecca L Tamas,et al.  Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype , 2003, Neuropsychopharmacology.

[158]  J. Campisi,et al.  Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. , 2003, Cell stress & chaperones.

[159]  J. Gilmore,et al.  Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal–fetal unit of the rat , 2003, Journal of Neuroimmunology.

[160]  S. Maier Bi-directional immune–brain communication: Implications for understanding stress, pain, and cognition , 2003, Brain, Behavior, and Immunity.

[161]  X. Zhang,et al.  Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology , 2002, Schizophrenia Research.

[162]  Jun Li,et al.  [Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children]. , 2002, Zhonghua yi xue za zhi.

[163]  J. Leon,et al.  Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders , 2002, Schizophrenia Research.

[164]  O. Oncul,et al.  Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia , 2002 .

[165]  S. Melmed,et al.  Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. , 2002, Endocrinology.

[166]  A. Rush,et al.  High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure , 2002, Biological Psychiatry.

[167]  P. Patterson,et al.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness , 2002, Current Opinion in Neurobiology.

[168]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[169]  S. Rivest How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis , 2001, Psychoneuroendocrinology.

[170]  B. Thisse,et al.  Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. , 2001, Developmental biology.

[171]  T. Sakai,et al.  Plasma cytokine response to surgical stress in schizophrenic patients , 2001, Clinical and experimental immunology.

[172]  Y. Pollak,et al.  Effects of Antidepressant Drugs on the Behavioral and Physiological Responses to Lipopolysaccharide (LPS) in Rodents , 2001, Neuropsychopharmacology.

[173]  J. Lieberman,et al.  Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain , 2001, Schizophrenia Research.

[174]  C. Stefanis,et al.  Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients , 2001, Schizophrenia Research.

[175]  Stanley Jacobson,et al.  Acute stress increases permeability of the blood–brain-barrier through activation of brain mast cells , 2001, Brain Research.

[176]  R. Dantzer,et al.  Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? , 2000, Autonomic Neuroscience.

[177]  Masanori Kato,et al.  Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases , 2000, Brain Research.

[178]  Yong-Ku Kim,et al.  Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics , 2000, Schizophrenia Research.

[179]  R. Dantzer,et al.  Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[180]  S. Arnold,et al.  Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia , 2000, Psychiatry Research.

[181]  R. Pioli,et al.  Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics , 2000, European Neuropsychopharmacology.

[182]  L. Garey,et al.  Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.

[183]  R. Dantzer,et al.  Increased Sensitivity of Prediabetic Nonobese Diabetic Mouse to the Behavioral Effects of IL-1 , 1999, Brain, Behavior, and Immunity.

[184]  W. Banks,et al.  Peptides crossing the blood–brain barrier: some unusual observations , 1999, Brain Research.

[185]  B. Pessac,et al.  Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. , 1999, Brain research. Developmental brain research.

[186]  R. Rimón,et al.  Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. , 1999, The American journal of psychiatry.

[187]  J. Kelly,et al.  Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. , 1999, Life sciences.

[188]  T. Pollmächer,et al.  Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. , 1999, Journal of psychiatric research.

[189]  P. Falkai,et al.  Evidence for activation of microglia in patients with psychiatric illnesses , 1999, Neuroscience Letters.

[190]  P. Rezaie,et al.  Microglia in the human fetal spinal cord--patterns of distribution, morphology and phenotype. , 1999, Brain research. Developmental brain research.

[191]  T. Lundeberg,et al.  Activation of Vagal Afferents after Intravenous Injection of Interleukin-1β: Role of Endogenous Prostaglandins , 1998, The Journal of Neuroscience.

[192]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[193]  R. Pioli,et al.  The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.

[194]  V. Arolt,et al.  Immunological Dysfunction in Schizophrenia: A Systematic Approach , 1998, Neuropsychobiology.

[195]  J. Trojanowski,et al.  Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. , 1998, Archives of general psychiatry.

[196]  J. Mege,et al.  A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia? , 1997, Schizophrenia Research.

[197]  M. Maj,et al.  Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment , 1997, Psychiatry Research.

[198]  Dennis J. Rivet,et al.  Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia , 1997, The Journal of experimental medicine.

[199]  J. Zimmer,et al.  Development of microglia in the prenatal rat hippocampus , 1997, The Journal of comparative neurology.

[200]  Tyrone D. Cannon,et al.  Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease? , 1996, Biological Psychiatry.

[201]  R. Dantzer,et al.  Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. , 1996, Neuroreport.

[202]  R. Yirmiya Endotoxin produces a depressive-like episode in rats , 1996, Brain Research.

[203]  M. A. Cuadros,et al.  Macrophages during avian optic nerve development: relationship to cell death and differentiation into microglia , 1996, Anatomy and Embryology.

[204]  M. Mallat,et al.  Immunohistochemical detection of thrombospondin in microglia in the developing rat brain , 1995, Neuroscience.

[205]  R. S. Smith,et al.  The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. , 1995, Medical hypotheses.

[206]  F. Chaouloff,et al.  Glucose, insulin, and open field responses to immobilization in nonobese diabetic (NOD) mice , 1994, Physiology & Behavior.

[207]  M. Mallat,et al.  Brain macrophages stimulate neurite growth and regeneration by secreting thrombospondin , 1994, Journal of neuroscience research.

[208]  M. Mitchell,et al.  Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha. , 1994, Biology of reproduction.

[209]  H. Y. Meltzer,et al.  Immune‐inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine , 1994, Acta psychiatrica Scandinavica.

[210]  R. Butterworth,et al.  Increased Densities of Binding Sites for the “Peripheral-Type” Benzodiazepine Receptor Ligand [3H]PK11195 in Vulnerable Regions of the Rat Brain in Thiamine Deficiency Encephalopathy , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[211]  A. Almendros,et al.  First appearance, distribution, and origin of macrophages in the early development of the avian central nervous system , 1993, The Journal of comparative neurology.

[212]  H. Saito,et al.  Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain , 1993, Journal of neuroscience research.

[213]  R. S. Smith A comprehensive macrophage-T-lymphocyte theory of schizophrenia. , 1992, Medical hypotheses.

[214]  M. A. Cuadros,et al.  Haemopoietic phagocytes in the early differentiating avian retina. , 1991, Journal of anatomy.

[215]  K. Ashwell,et al.  Development of microglia in the albino rabbit retina , 1989, The Journal of comparative neurology.

[216]  J. Stone,et al.  The appearance and distribution of microglia in the developing retina of the rat , 1989, Visual Neuroscience.

[217]  G. Innocenti,et al.  Transitory macrophages in the white matter of the developing visual cortex. II. Development and relations with axonal pathways. , 1983, Brain research.

[218]  Ling Ea Some aspects of amoeboid microglia in the corpus callosum and neighbouring regions of neonatal rats. , 1976 .

[219]  J. Korf,et al.  The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. , 2012, Journal of Alzheimer's disease : JAD.

[220]  R. Dantzer,et al.  Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. , 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[221]  Hymie Anisman,et al.  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[222]  M. Schwarz,et al.  Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[223]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[224]  J. Bauer,et al.  Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[225]  J. M. Friedman,et al.  Extracellular Hsp 72: A Double-Edged Sword for Host Defense , 2007 .

[226]  R. Keep,et al.  Inflammation and brain edema: new insights into the role of chemokines and their receptors. , 2006, Acta neurochirurgica. Supplement.

[227]  S. Poole,et al.  The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia , 2006, Molecular Psychiatry.

[228]  A. Scheen,et al.  Clinical Practice and Epidemiology in Mental Health Prevalence of Diabetes, Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia over the Course of the Illness: a Cross-sectional Study , 2006 .

[229]  B. Schmidt-Sidor,et al.  Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics. , 2004, Folia neuropathologica.

[230]  T. Kamińska,et al.  Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients. , 2001, Archivum immunologiae et therapiae experimentalis.

[231]  Y. Pang,et al.  Cytokine Induction in Fetal Rat Brains and Brain Injury in Neonatal Rats after Maternal Lipopolysaccharide Administration , 2000, Pediatric Research.

[232]  Y. Barde,et al.  Microglia-Derived Nerve Growth Factor Causes Cell Death in the Developing Retina , 1998, Neuron.

[233]  Su-Chun Zhang,et al.  Neuron-microglia interactions in vitro , 1996, Acta Neuropathologica.

[234]  R. Dantzer,et al.  Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[235]  E. Ling Some aspects of amoeboid microglia in the corpus callosum and neighbouring regions of neonatal rats. , 1976, Journal of anatomy.

[236]  H. Herken,et al.  Research Paper Mediators of Inflammation, 10, 109–115 (2001) ACTIVAT ION of the inflammatory response system and , 2022 .